Results 161 to 170 of about 19,420 (199)
Recurrent Venous Thrombosis with a “Lupus” Coagulation Inhibitor in the Absence of Systemic Lupus
Australian and New Zealand Journal of Medicine, 1977 A young man presenting with recurrent deep venous thrombosis was found to have a lupus type coagulation inhibitor. He showed neither clinical nor serological evidence of systemic lupus. The value of the Russell viper venom coagulation time in the detection of the inhibitor is demonstrated.
A. Manoharan +3 more
openalex +3 more sources
Studies on Phospholipids in the Action of a Lupus Coagulation Inhibitor
Pathology, 1975 Plasma from a patient with early manifestations of disseminated lupus erythematosus, a prolonged partial thromboplastin time with kaolin, mildly prolonged prothrombin time, and a circulating inhibitor affecting the assay of several clotting factors was investigated.
Thomas Exner +2 more
openalex +3 more sources
A Circulating Lupus-like Coagulation Inhibitor Induced by Chlorpromazine
Journal of Clinical Psychopharmacology, 1984 A variety of immune phenomena have been associated with chlorpromazine. One such factor, the lupus-like anticoagulant, while nonspecific, has been reported in 26 to 75% of chronic chlorpromazine recipients, although the exact incidence is unknown and requires further investigation.
Gary D. Tollefson +2 more
openalex +3 more sources
Circulating inhibitors of blood coagulation associated with procainamide‐induced lupus erythematosus
American Journal of Hematology, 1978 AbstractWe studied a patient being treated with procainamide in whom we observed a high antinuclear antibody titer and prolonged activated partial thromboplastin (PTT), prothrombin (PT), and Stypven times (ST). Serum antibody concentrations against single‐stranded DNA were elevated while those against native DNA were not elevated, suggesting the ...
Stephen Davis +3 more
openalex +3 more sources
Reumatología Clínica (English Edition), 2008 Hematologic signs of systemic lupus erythematosus are diverse (SLE). Although a delayed coagulation time is anti-phospholipid antibody related, thrombotic events are the usual clinical manifestation. Spontaneous appearance of circulating anticoagulant in the absence of a previous coagulation disorder is secondary to the development of antibodies to ...
Enrique Ortiz Jiménez +2 more
openalex +3 more sources
Natural inhibitors of blood coagulation and fibrinolysis in patients with lupus anticoagulant
Blood Coagulation & Fibrinolysis, 1992 We studied the natural inhibitors (NI) of blood coagulation and fibrinolysis in 50 patients with lupus anticoagulant (LA), in order to identify possible alterations of these NI, that could favour thrombotic manifestations. We found no statistically significant difference in antithrombin III, protein C and alpha 2-antiplasmin between controls and ...
L Kordich +4 more
openalex +3 more sources
International Journal of Laboratory HematologyAbstractIntroductionMixing tests in activated partial thromboplastin time (APTT) are used for the differentiation between lupus anticoagulants (LA), coagulation inhibitors, and factor deficient samples with APTT prolongation. However, the indexes for the differentiation have not been established.
Daiki Shimomura +6 more
openalex +3 more sources
The lupus coagulation inhibitor and venous thrombosis: a report of four cases
Clinical & Laboratory Haematology, 1980 Hywel Williams, R. Laurent, T. Gibson
openalex +3 more sources
LUPUS‐TYPE COAGULATION INHIBITOR IN HAIRY CELL LEUKAEMIA AND REOSOLUTION WITH SPLENECTOMY
British Journal of Haematology, 1987 A. S. Duncombe +2 more
openalex +2 more sources